What's Hot

    Delta flights delayed attributable to automated system concern (DAL:NYSE) | Invesloan.com

    November 22, 2026

    FDA authorizes Virtuoso robotic surgical procedure system for bladder tumor elimination | Invesloan.com

    November 22, 2026

    Corporate America hunts for ‘generational’ development in AI, buying and selling playing cards and the L.A. airport | Invesloan.com

    November 22, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » FDA authorizes Virtuoso robotic surgical procedure system for bladder tumor elimination | Invesloan.com
    Politics

    FDA authorizes Virtuoso robotic surgical procedure system for bladder tumor elimination | Invesloan.com

    November 22, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email

    NEWYou can now listen to Fox News articles!

    If a doctor finds a tumor in your bladder, you want to know what you’re dealing with. Is it cancer? Has it reached the bladder muscle? The tissue removed during surgery helps answer those questions. Now, a tiny surgical robot could give doctors a clearer view of what’s happening inside the bladder.

    The FDA has authorized the Virtuoso Endoscopy System, developed by Nashville-based Virtuoso Surgical. It uses two needle-sized robotic arms to remove bladder lesions through the urethra, without cutting through the skin. The technology allows surgeons to remove many tumors in one piece, potentially giving pathologists better tissue samples to examine. This new approach to robotic bladder tumor removal could help doctors make more informed treatment decisions.

    Missed CyberGuy LIVE? Watch the replay and discover 5 ways to travel smarter and save money.

    Our free CyberGuy LIVE class, 5 Ways to Travel Smarter and Save Money, has ended, but you can still watch the full replay. Kurt “CyberGuy” Knutsson walks you through five practical ways to protect your phone and personal information, avoid common travel scams, find better deals, save money on bookings and use technology to make your travels easier and less stressful. No technical experience is needed.

    Watch the free replay + downloadable checklist now at CyberGuyLive.com.

    WOULD YOU TRUST A TINY DENTAL ROBOT?

    A view of a small robotic surgical device designed for minimally invasive bladder tumor removal procedures.

    The FDA-authorized Virtuoso Endoscopy System uses two miniature robotic arms to help surgeons remove bladder lesions through the urethra without external incisions. ( (Virtuoso Surgical)

    How robotic bladder tumor removal works

    The Virtuoso Endoscopy System uses a narrow medical instrument called a rigid endoscope, which enters the bladder through the urethra. At the tip are two miniature robotic arms made from a flexible metal alloy called nitinol. A surgeon controls both arms from a console. One arm lifts and holds the tumor while the other carefully separates it from the tissue underneath. This gives the surgeon two-handed control inside a very small space.

    The technique is called en bloc resection, which means removing a tumor in one piece. Surgeons can already perform this procedure using conventional instruments, but it can be technically demanding. Virtuoso designed its system to make that approach easier to perform. The robot also relies entirely on the surgeon’s movements. Unlike some autonomous surgical robots being tested in research settings, Virtuoso does not make surgical decisions or operate independently.

    Why removing bladder tumors in one piece could help

    Bladder cancer affects thousands of Americans every year. The American Cancer Society estimates that approximately 84,530 people in the United States will receive a bladder cancer diagnosis in 2026. One of the most common procedures for evaluating and removing bladder tumors is called transurethral resection of bladder tumor, or TURBT. During conventional TURBT, surgeons often remove tumors in smaller fragments. While effective for many patients, that approach can disrupt the tissue’s original structure. As a result, pathologists may have a harder time determining how deeply cancer has grown. That’s particularly important when it comes to the bladder’s muscle layer, called the detrusor muscle. Doctors need to know whether cancer has reached this muscle because that can change the recommended treatment.

    Removing a lesion intact may preserve more of the information pathologists need. It can also allow them to examine the tissue around the tumor more clearly. Dr. Duke Herrell, a urologic surgeon and CEO of Virtuoso Surgical, explained the potential benefit in the company’s FDA announcement. “Removing a tumor intact can provide a better tissue specimen, which supports clearer diagnosis and staging,” Herrell said. For patients, a more complete tissue sample could help their medical team determine the next steps with greater confidence.

    Early results show promise for the tiny surgical robot

    Virtuoso has already tested the system in human patients, and the early clinical findings are encouraging. In the first 20 patients enrolled in the company-sponsored VIABLE study at The Chinese University of Hong Kong, 94% of removed lesions contained detrusor muscle. That exceeded the study’s predefined performance goal of 60%. Researchers also reported that surgical margins could be evaluated in 93% of malignant lesions. Surgical margins are the edges of the removed tissue. Examining them can help doctors assess whether cancer cells extend to the edge of the sample. However, being able to evaluate a margin does not necessarily mean it is free of cancer. The company reported no adverse events during the operations.

    There are important limitations to these findings. The study involved a small number of patients at one medical center. The previously published first phase of the same VIABLE study involved six patients and recorded two postoperative adverse events. One patient experienced temporary urinary retention, while another developed a chest infection later linked to a separate esophageal tumor. The company also compared its results with previously published research on conventional bladder tumor removal.

    However, the Virtuoso study did not directly compare the robot against traditional instruments in a randomized trial. Researchers still need larger studies to determine whether the system improves long-term outcomes or reduces the need for additional procedures.

    BRAIN TUMOR FOUND DURING PREVENTIVE SCAN PUTS FULL-BODY MRIS BACK IN THE SPOTLIGHT

    A surgical control console

    The Virtuoso Surgical control console allows surgeons to independently guide two tiny robotic arms during bladder tumor removal procedures. (Virtuoso Surgical)

    What the FDA authorized for bladder tumor surgery

    The FDA granted De Novo authorization for the Virtuoso Endoscopy System on October 30, 2026. The company publicly announced the decision on November 10. The authorization establishes a new FDA classification for robotic surgical instruments that operate through an endoscope inside the body. Specifically, the system is authorized to remove bladder lesions in adult patients and obtain tissue samples, including bladder muscle, to assist in diagnosing bladder cancer.

    The decision follows the FDA’s September 2025 Breakthrough Device Designation for the system. That earlier designation recognized the technology’s potential and allowed the company to receive additional regulatory guidance during development. However, the new authorization does not establish that the robot improves survival rates or prevents cancer from returning. The system must also be operated by trained surgeons in an operating room.

    When will hospitals start using this surgical robot?

    Virtuoso Surgical plans a limited U.S. launch in 2027, starting with leading urology centers. The company has not announced which hospitals will receive the system first. That means patients may have to wait before the technology becomes available at their local hospital. Questions also remain about pricing and insurance coverage.

    Virtuoso is exploring other potential applications for its miniature robotic instruments, including procedures involving the lungs. However, those uses remain experimental and have not received FDA authorization. For now, the company’s focus is bladder surgery, where better tissue samples could help doctors evaluate cancer more accurately.

    Robot arms next to a penny

    Virtuoso Surgical’s miniature instruments, shown next to a penny for scale, are designed to remove bladder lesions in one piece, potentially improving cancer diagnosis and staging. (Virtuoso Surgical)

    What this means to you

    If you or someone you love is facing bladder cancer, this technology could eventually provide another surgical option. Its miniature robotic arms may help doctors obtain more complete tissue samples during the initial procedure. However, availability will be limited at first, and the early results still need confirmation in larger studies. The robot’s FDA authorization also does not guarantee better results for every patient.

    If you’re discussing bladder tumor surgery with a urologist, ask whether en bloc resection might be appropriate for your situation. You should also ask how the surgeon plans to obtain enough tissue to determine whether cancer has reached the bladder muscle. Those answers can help you understand your options before surgery.

    Kurt’s key takeaways

    When you’re facing a possible cancer diagnosis, getting accurate answers as early as possible can make a real difference. That’s what I like about this technology. Virtuoso’s tiny robotic arms could help surgeons collect better tissue samples without taking control away from the medical professional performing the operation. It’s also encouraging to see the FDA authorize a system designed for such a specific surgical challenge. Still, 20 patients represent a very small study, and I want to see how this robot performs in larger trials before getting too excited about its potential. If the results hold up, this could become a valuable addition to the tools doctors use to diagnose bladder cancer.

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Would you trust a surgeon using this new robotic system to remove a tumor, or would you prefer a conventional procedure until there’s more evidence of its benefits? Let us know by writing to us at Cyberguy.com

    Sign up for my FREE CyberGuy Newsletter

    • Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox.
    • For simple, real-world ways to spot scams early and stay protected, visit CyberGuy.com – trusted by millions who watch CyberGuy on TV daily.
    • Plus, you’ll get instant access to my Ultimate Scam Survival Guide free when you join.

    Copyright 2026 CyberGuy.com. All rights reserved.

    Kurt “CyberGuy” Knutsson is an award-winning tech journalist who has a deep love of technology, gear and gadgets that make life better with his contributions for Fox News & FOX Business beginning mornings on “FOX & Friends.” Got a tech question? Get Kurt’s free CyberGuy Newsletter, share your voice, a story idea or comment at CyberGuy.com.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    House Democrats push $25 minimal wage to struggle affordability disaster | Invesloan.com

    Underdog Promo Code FOXNEWS: Play $10, Get $50 on 49ers vs Vikings Sunday Night Football | Invesloan.com

    Timelime of Fiona the hippo’s life on the Cincinnati Zoo, why thousands and thousands mourn her | Invesloan.com

    Lawsuit challenges Newsom’s commutation of 548 California loss of life sentences | Invesloan.com

    Illegal immigrant’s expenses dropped in Florida Publix parking zone loss of life | Invesloan.com

    Hakeem Jeffries as soon as referred to as Jerusalem the ‘sixth Borough’ of New York City | Invesloan.com

    Pennsylvania Farm Supplies White House Thanksgiving Turkeys | Invesloan.com

    Georgia has prime College Football Playoff seed in sight with dominating highway win over No 21 South Carolina | Invesloan.com

    This non-toxic slicing board is as much as 40% off — and it even sharpens knives | Invesloan.com

    LATEST NEWS

    Delta flights delayed attributable to automated system concern (DAL:NYSE) | Invesloan.com

    November 22, 2026

    FDA authorizes Virtuoso robotic surgical procedure system for bladder tumor elimination | Invesloan.com

    November 22, 2026

    Corporate America hunts for ‘generational’ development in AI, buying and selling playing cards and the L.A. airport | Invesloan.com

    November 22, 2026

    House Democrats push $25 minimal wage to struggle affordability disaster | Invesloan.com

    November 22, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}